Cart summary

You have no items in your shopping cart.

Taurochenodeoxycholic acid sodium

SKU: orb1297206

Description

Taurochenodeoxycholic acid sodium

Research Area

Cell Biology, Metabolism Research

Images & Validation

Key Properties

CAS Number6009-98-9
MW521.68
Purity99.56%
FormulaC26H44NNaO6S
SMILES[Na+].C[C@H](CCC(=O)NCCS([O-])(=O)=O)[C@H]1CC[C@H]2[C@@H]3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)[C@H]3CC[C@]12C
TargetEndogenous Metabolite,Apoptosis
Solubility10% DMSO+40% PEG300+5% Tween-80+45% Saline:2 mg/mL (3.83 mM);DMSO:262.5 mg/mL (503.18 mM)

Bioactivity

In Vitro
Experiments were performed with islets from wild-type, farnesoid X receptor (FXR) knockout (KO), and β-cell ATP-dependent K(+) (K(ATP)) channel gene SUR1 (ABCC8) KO mice, respectively Sodium taurochenodeoxycholate (TCDC) increased glucose-induced Insulin secretion. This effect was mimicked b the FXR agonist GW4064 and suppressed b the FXR antagonist guggulsterone. TCDC and GW4064 stimulate the electrical activity of β-cells and enhanced cytosolic Ca(2+) concentration [Ca(2+)](c)). These effects were blunted by guggulsterone. Sodium ursodeoxycholate, which has a much lower affinity to FXR than TCDC, had no effect on [Ca(2+)](c) and Insulin secretion. FXR activation by TCDC is suggested to inhibit K(ATP) current the decline in K(ATP) channel activity by TCDC was only observed in β-cells with intact metabolism and was reversed by guggulsterone. TCDC did not alter Insulin secretion in islets of SUR1-KO or FXR-KO mice. TCDC did not change islet cell apoptosis.

Storage & Handling

StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
DisclaimerFor research use only

Alternative Names

inhibit, NR8383, JNK, immune, mRNA, Inhibitor, EndogenousMetabolite, Endogenous Metabolite, Calcium Channel, caspase-3, caspase-8, bile, anti-inflammatory, apoptosis, Apoptosis, ATPase, acid, 12-Deoxycholyltaurine, TNF-α, PKC, TIMP-2, Potassium Channel, Taurochenodeoxycholic acid, Taurochenodeoxycholic acid sodium, Sodium taurochenodeoxycholate, regulation

Similar Products

Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

Taurochenodeoxycholic acid sodium (orb1297206)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

1 ml x 10 mM (in DMSO)
¥ 1,170.00
100 mg
¥ 1,170.00
DispatchUsually dispatched within 3-5 working days
Bulk Enquiry